利拉鲁肽是一款新型胰高血糖素样肽-1受体激动剂（ GLP⁃１ＲＡ），目前主要通过基因重组改造的酒酿...
In comes Pfizer’s danuglipron, an oral GLP-1 receptor agonist. As one of the world’s largest pharmaceutical companies, Pfizer’s entry into the obesity market with an oral med could change the game for weight loss treatments. Let’s get into what danuglipron is, how it works and what...
ID110521156 is the GLP-1 receptor agonist (glucagon-like peptide-1 receptor agonist) family of drugs and acts as an analog of the GLP-1 hormone, which regulates blood sugar levels by inducing insulin secretion in the body. GLP-1 hormone is produced by beta cells in the pancreas. It is i...